AUROPHARMA / margins history

Follow the number, quarter by quarter.

Aurobindo Pharma · EBITDA margin (%) across the available source records.

Research layer active

Metric history

EBITDA margin (%)

10 actual points
EBITDA margin (%)PositiveWatchNegative
10 actual records
Actual quarterly EBITDA margin (%) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY24: 16.8 · Positive source sentiment · 2023-08-14Q1 FY24Q1 FY25: 21.4 · Positive source sentiment · 2024-08-12Q1 FY25Q1 FY26: 20 · Watch source sentiment · 2025-08-14Q1 FY26Q2 FY24: 19.4 · Positive source sentiment · 2023-11-09Q2 FY24Q2 FY25: 20.1 · Positive source sentiment · 2024-11-11Q2 FY25Q2 FY26: 20.3 · Positive source sentiment · 2025-11-14Q2 FY26Q3 FY24: 21.8 · Positive source sentiment · 2024-02-12Q3 FY24Q3 FY25: 20.4 · Positive source sentiment · 2025-02-12Q3 FY25Q4 FY24: 22 · Positive source sentiment · 2024-05-27Q4 FY24Q4 FY25: 21.4 · Positive source sentiment · 2025-05-15Q4 FY252216.8
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.
Q1 FY2416.8Q1 FY2521.4Q1 FY2620Q2 FY2419.4Q2 FY2520.1Q2 FY2620.3Q3 FY2421.8Q3 FY2520.4Q4 FY2422Q4 FY2521.4